Plunkett Research Online: Cyclacel Pharmaceuticals Inc.

CYCLACEL PHARMACEUTICALS INC. (CYCC) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitor.....


CYCLACEL PHARMACEUTICALS INC.

Ticker: CYCC
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 908 517-7330
Fax:
Address: 200 Connell Drive
Berkeley Heights, NJ 07922 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

David LazarCEO/CFO
Paul McBarronCFO/Chief Accounting Officer/COO/Director/Executive VP, Divisional/Secretary
See More
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitor.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture